High cholesterol levels greatly increase the risk of cardiovascular disease. About 50 per cent of cholesterol is eliminated from the body by its conversion into bile acids. However, bile acids released from the bile duct are constantly recycled, being reabsorbed in the intestine by the apical sodium-dependent bile acid transporter (ASBT, also known as SLC10A2). It has been shown in animal models that plasma cholesterol levels are considerably lowered by specific inhibitors of ASBT 1,2 , and ASBT is thus a target for hypercholesterolaemia drugs. Here we report the crystal structure of a bacterial homologue of ASBT from Neisseria meningitidis (ASBT NM ) at 2.2 Å . ASBT NM contains two inverted structural repeats of five transmembrane helices. A core domain of six helices harbours two sodium ions, and the remaining four helices pack in a row to form a flat, 'panel'-like domain. Overall, the architecture of the protein is remarkably similar to the sodium/proton antiporter NhaA 3 , despite having no detectable sequence homology. The ASBT NM structure was captured with the substrate taurocholate present, bound between the core and panel domains in a large, inward-facing, hydrophobic cavity. Residues near this cavity have been shown to affect the binding of specific inhibitors of human ASBT 4 . The position of the taurocholate molecule, together with the molecular architecture, suggests the rudiments of a possible transport mechanism.
ASBT is an SLC10 (sodium bile acid co-transporter family) member that moves bile acids across the apical membrane of the ileum into the portal blood vein 5, 6 . ASBT uses the sodium ion gradient to drive the 'uphill' transport of bile acids across membranes, with a reported stoichiometry of two sodium ions per substrate 7 . Mutations in the human ASBT gene cause a condition of primary bile acid malabsorption 8 . ASBT is a pharmaceutical target for drugs aimed at lowering cholesterol, and several ASBT inhibitors have been developed that are effective in animal models 1, 2 . Because some drugs are poorly absorbed in the intestine or need to be targeted to the liver, ASBT and its close liver paralogue, NTCP (SLC10A1), have also received attention as prodrug carriers, capable of transporting various compounds coupled to bile acid, for example HMG-CoA reductase (HMGCR) inhibitors, the antiviral drug acyclovir, nucleotides and cytostatic drugs 9 .
ASBT NM from N. meningitidis, with 26% identity and 54% similarity to human ASBT, was identified by fluorescence-based screening methods 10, 11 as a suitable candidate for structural studies (Supplementary Figs 1 and 2). Residues known to be functionally important in mammalian ASBT and other SLC10 members 12 are well conserved in ASBT NM ( Supplementary Fig. 1 ). Bile acid transport by ASBT NM was confirmed in whole cells by the sodium-dependent uptake of [ 3 H]taurocholate (Fig. 1a ). The observed Michaelis constant, K m , for [ 3 H]taurocholate is ,50 mM ( Fig. 1b ), a value similar to that measured for rat and human ASBT 7, 13, 14 . The ASBT inhibitors cyclosporin A 15 and bromosulfophthalein 15 and the drug fluvastatin 16 are also competitors for ASBT NM -mediated [ 3 H]-taurocholate transport (Fig. 1c ). Thus, ASBT NM is a valid model of mammalian bile acid transporters. We solved the structure of ASBT NM by single-wavelength anomalous scattering and refined it at a resolution of 2.2 Å (Supplementary Tables 1  and 2 ; Methods).
ASBT NM has cytoplasmic amino and carboxy termini, comprises ten transmembrane helices (TMs) that are linked by short loops, and has overall dimensions of approximately 45 Å 3 30 Å 3 30 Å ( Fig. 2 and Supplementary Fig. 3 ). TM1 to TM5 and TM6 to TM10 are topologically similar but oppositely orientated in the plane of the ) , measured as a percentage of the uptake without their addition (white bar). d, ASBT NM -mediated [ 3 H]-taurocholate uptake after 5 min for a wild-type control (white bar) and the indicated single alanine point mutants (black bars). The uptake for the mutants is displayed as a percentage of the wild-type activity. The expression and detergent-solubilized folded state of each mutant was similar to wild-type protein ( Supplementary  Fig. 2a ). Errors bars, s.e.m.; n 5 3.
membrane. The root mean squared deviation (r.m.s.d.) after superposition of the two topology-inverted repeats is 3.7 Å ( Supplementary  Fig. 4a , b; Methods). Each repeating unit is made of an N-terminal V-motif (TM1 and TM2, TM6 and TM7) and a core motif of three helices (TM3 to TM5, TM8 to TM10) ( Fig. 2 and Supplementary Figs 3  and 4 ). If the V-motif and the core motif are superposed separately, the r.m.s.d. in each case is lower: 2.6 Å and 2.8 Å , respectively (Supplementary Fig. 4c ). The core motifs from each repeat form the core domain, whereas the two V-motifs create a panel-like domain ( Fig. 2b ). TM4 and TM9 in the core domain are broken in the middle (discontinuous) and form helical hairpins with TM5 and TM10, respectively, which are both kinked. At the point where TM4 and TM9 are broken by well-conserved peptide motifs, they cross over ( Fig. 2 and Supplementary Figs 5 and 6 ). On the intracellular side, a wide crevice separates the core domain from the panel domain (Fig. 3a ). The cavity extends over halfway through the protein. The extracellular side of the cavity is tightly closed by TM1, TM2, TM4b, TM7, TM9b and TM10. Previously, two topology models of ASBT were proposed with seven and nine transmembrane helices, respectively 17, 18 . Because TM1 is not conserved in ASBT, the structure is broadly consistent with the model with nine transmembrane helices ( Supplementary Fig. 5 ). TM4 and TM9 were annotated as extracellular loops in the topology model with seven transmembrane helices, but were correctly identified in the model with nine transmembrane helices. Discontinuous transmembrane helices are a common motif in secondary active transporters 3, 19, 20 . However, the sodium/proton antiporter NhaA is the only other known example in which these helices cross as observed in ASBT NM ( Supplementary Fig. 6 ). Indeed, ASBT NM has a similar structure to NhaA, and they superpose with an r.m.s.d. of 2.9 Å over 202 Ca atoms ( Supplementary Fig. 7a ; Methods). The similarity is more striking when the core and panel domains are superposed separately ( Supplementary Fig. 7b ). This unexpected finding further emphasizes the remarkable plasticity of transporters, which allows them to use a common scaffold to translocate different substrates 20 .
In ASBT and NTCP, two sodium ions are translocated per bile acid molecule 7, 21 . In the highly conserved core domain of ASBT NM ( Supplementary Fig. 8 ), we have identified two sodium-binding sites (Na1 and Na2) on the basis of the coordination and bond distances (2.0-2.5 Å ) ( Fig. 3b and Supplementary Figs 9a and 10a; Methods). Na1 is located approximately 10 Å from the cytoplasmic surface between TM4b and TM5, but also interacts with the carboxylate moiety of Glu 260 on TM9a ( Fig. 3b and Supplementary Fig. 10a ). The Na2 site is located 8 Å from Na1, near the centre at the crossover points of TM4a with TM4b and TM9a with TM9b. Four backbone carbonyl oxygen atoms coordinate Na2, including Glu 260 on TM9a and the side chains of Gln 264 on TM9a and Gln 77 on TM3. The residues for which the side chains interact with the two sodium ions are completely conserved in ASBT and NTCP ( Supplementary Figs 5 and 8 ). The glutamate residue equivalent to Glu 260 is essential for activity in ASBT and NTCP 13, 22 . In ASBT NM , its replacement with alanine significantly affects transport, as does the mutation of Gln 77 to alanine ( Fig. 1d and Supplementary Fig. 2a ). Thus, it seems that both sodium ions are required for efficient transport. Mechanistically, it is almost certainly necessary for sodium to be present at the Na2 site to neutralize the partial negative dipole of TM9a and, by doing so, stabilize the interaction with TM4a. Neutralization of the helix dipoles seems a conserved feature for this fold. In NhaA, the corresponding transmembrane helix is thought to be neutralized by the positive charge of Lys 300, which is essential for transport 3, 23 .
The substrate-binding cavity is open to the cytoplasm and is approximately 6 Å 3 12 Å 3 14 Å in size, with a solvent-accessible volume of 550 Å 3 (Fig. 3a; Methods) . Because the N-terminal half of TM1 is markedly bent outwards, it is more open on one side. The in the plane of the membrane. TM1 to TM10 have been coloured from red at the N terminus to blue at the C terminus, and the position of the membrane is depicted in grey. The pink spheres indicate sodium sites Na1 and Na2, and the stick model represents the substrate taurocholate. b, ASBT NM structure as viewed from the intracellular side as a ribbon representation (left) and as a simplified cartoon (right). On the right, the burgundy pentagon represents taurocholate. 
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cavity is much bigger than taurocholate, perhaps reflecting the large variety of compounds that are recognized by ASBT 9,12,16 (Fig. 3a, c) . It is predominantly hydrophobic, but near the bottom there are a number of polar residues and water molecules ( Fig. 3c and Supplementary  Fig. 10b ). As judged from high B-factors, taurocholate seems to be weakly bound (Supplementary Table 2 and Supplementary Fig. 9b ). Consistent with this observation, there is only one direct hydrogen bond between ASBT NM and taurocholate, from Asn 295 on TM10 to the 7a hydroxyl group. The mutation of Asn 295 to alanine causes a dramatic reduction in taurocholate transport ( Fig. 1d and Supplementary Fig. 2a ). Water molecules bridge the 7a hydroxyl with His 294 and the 3a hydroxyl with Asn 265, which is located at the crossover region of TM9. Thr 112 is also in the vicinity of the 3a group but cannot be unambiguously placed. The 12a hydroxyl group does not have any apparent hydrogen-bonding partner. The taurine moiety binds between TM1 and TM10. Interaction of the taurocholate with residues in TM10 is in agreement with biochemical data, which indicate that the last helix in ASBT has a dominant role in the translocation process 24 .
The location of Asn 265 between the TM4b and TM9b dipoles suggests that it may have a role in the mechanism. The importance of this residue has been inferred from mutagenesis studies on NTCP 22 . If Asn 265 is replaced by alanine in ASBT NM , transporter activity is reduced by ,80% (Fig. 1d and Supplementary Fig. 2a ). Although there are clear similarities between the binding sites in ASBT NM and ASBT, there are also sequence differences ( Supplementary Fig. 5 ). Such differences may affect substrate specificity. For transport to take place, the protein must switch between outward-and inward-facing states 25 . The architecture of ASBT NM provides a clue to understanding how this might occur. The sodium ions are located in the core domain, close to the crossover points of the discontinuous helices and occluded from the bulk solvent. In NhaA, sodium binding causes a rearrangement of these helices 26, 27 . In ASBT NM , similar rearrangements in the core domain are therefore likely. Because NhaA translocates only protons and sodium ions 26 these helix movements might be sufficient for transport. However, ASBT NM transports much larger substrates, and structural movements in more than the core domain are therefore needed. For the sodiumcoupled transporter LeuT, the internal asymmetry of the repeating motifs has been used to predict global movements from a single structure 28 , and these movements have been substantiated by crystallographic studies 29 . In an analogous manner to LeuT, an outwardfacing model of ASBT NM was generated by superimposing TM1 to TM5 on TM6 to TM10, and vice versa ( Fig. 4a; Methods) . Comparing the inward-facing ASBT NM structure with the outward-facing model, the largest difference is the position of the panel domain relative to the core domain (Fig. 4a, c) . A route through the protein between these domains is in agreement with experimental data, which suggest that the final helix of ASBT and TM9 (IX) of NhaA line the transport pathway 3, 24, 26, 30 . Notably, the NhaA domain equivalent to the panel domain is located between that of the outward-facing and inwardfacing ASBT NM states (Fig. 4b ). This may be because NhaA translocates a much smaller substrate, or it could represent another conformation of the transporter, probably an occluded state.
We propose that sodium binding controls the conformation of the core domain of ASBT NM , which in turn drives the movement of the panel domain. This large conformational change of the panel domain relative to the core domain is required to alter the accessibility of the substrate-binding pocket. The ASBT NM structure should aid the design of new inhibitors against ASBT with the goal of treating hypercholesterolaemia. Figure 4 | Putative mechanism for ASBT NM transport. a, Superposition of the ASBT NM structure (red, panel domain; blue, core domain) and the outward-facing model as described in the text (light grey). The superposition has been optimized on the core domains. Loops have been removed for clarity. In the right-hand image, the panel domain of the model has been rotated by 25u relative to the core domain, around the axis shown in the left-hand image, to superimpose the panel domains. Significant kinks in the helices are represented as breaks. The area of the cavity is depicted by a tan-coloured trapezoid.
Transmembrane helices are numbered from 1 to 10; those coloured grey and labelled with an asterisk represent the helices in the outward-facing model. b, NhaA shown in the same view as ASBT NM in a. The core domain is shown in light blue and the panel domain is shown in maroon. The two additional transmembrane helices and b-strands that are not present in ASBT NM are shown in grey. The position where sodium is thought to bind 3 is shown with a black ring. c, Proposed transport mechanism, illustrating the movement of the panel domain relative to the core domain to transport sodium and bile acid.
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METHODS SUMMARY
ASBT NM was cloned into a cleavable green fluorescent protein (GFP)/His 8 fusion vector, pWaldoGFPe 10 . The fusion protein was expressed in E. coli, solubilized in 1% dodecyl-b-D-maltopyranoside and purified to homogeneity. Before crystallization, untagged ASBT NM was exchanged into 0.06% n-dodecyl-N,N-dimthylamine-N-oxide by size-exclusion chromatography. Crystals were grown in the presence of 10 mM taurocholate by the vapour diffusion method. Data were collected on beamlines I02 and I03 at the Diamond Light Source, UK, dehydration of the crystals being necessary to collect high-resolution data. The protein was derivatized by short-soaking a surface-engineered cysteine mutant (ASBT NM_1 ) with 1 mM mercury acetate. The structure of ASBT NM_1 was solved by singlewavelength anomalous dispersion and subsequently refined against data collected from ASBT NM at a resolution of 2.2 Å . The cell-based bile acid uptake assay for ASBT NM was modified from that previously described 6 .
METHODS ASBT NM sequence. MNILSKISSFIGKTFSLWAALFAAAAFFAPDTFKWAGPY IPWLLGIIMFGMGLTLKPSDFDILFKHPKVVIIGVIAQFAIMPATAWLLSKLL NLPAEIAVGVILVGCCPGGTASNVMTYLARGNVALSVAVTSVSTLISPLLTP AIFLMLAGEMLEIQAAGMLMSIVKMVLLPIVLGLIVHKVLGSKTEKLTDALP LVSVAAIVLIIGAVVGASKGKIMESGLLIFAVVVLHNGIGYLLGFFAAKWTG LPYDAQKTLTIEVGMQNSGLAAALAAAHFAAAPVVAVPGALFSVWHNISG SLLATYWAAKAGKHKKPGSENLYFQ ASBT NM_1 sequence for structure solution. MVAASMNILSKISSFIGKTFSLW AALFAAAAFFAPDTFKWAGPYIPWLLGIIMFGMGLTLKPSDFDILFKHPKV VIIGVIAQFAIMPATAWCLSKLLNLPAEIAVGVILVGCCPGGTASNVMTYL ARGNVALSVAVTSVSTLTSPLLTPAIFLMLAGEMLEIQAAGMLMSIVKMVL LPIVLGLIVHKVLGSKTEKLTDALPLVSVAAIVLIIGAVVGASKGKIMESGLL IFAVVVLHNGIGYLLGFFAAKWTGLPYDAQKALTIEVGMQNSGLAAALAA AHFAAAPVVAVPGALFSVWHNISGSLLATYWAAKAGKHKKPLDRAGSEN LYFQ Expression screening, mutagenesis and protein purification. Bacterial ASBT homologues were cloned as GFP-His 8 fusions into the vector pWaldoGFPe 10 , as fluorescence from a C-terminal GFP fusion is a reliable reporter of membraneintegrated expression 31 . Fusions were overexpressed in E. coli C43(DE3) cells 32 by the addition of 0.4 mM IPTG at A 600nm 0.4. The temperature was decreased to 25 uC for overnight induction. The monodispersity of expressed fusions were screened in crude DDM-, decyl-b-D-maltopyranoside-, nonyl-b-D-maltopyranoside-, LDAO-or dodecyl nonaethylene glycol ether (C 12 E 9 )-solubilized membranes by fluorescence-detection size-exclusion chromatography 33 (FSEC). The ASBT NM homologue from N. meningitidis (MC58) was selected for structural studies on the basis of the amount of protein produced, as judged by whole-cell 31 and in-gel fluorescence 10 and the quality of the FSEC trace in different detergents. Site-directed mutants of ASBT NM were generated by PCR (Quickchange, Agilent Technologies).
Wild-type ASBT NM and mutants were purified essentially as previously described 34 . In brief, membranes were isolated from 10-l E. coli cultures and solubilized in 1% DDM for 2 h in buffer containing 31 PBS, 150 mM NaCl and 10 mM imidazole. The suspension was cleared by ultracentrifugation at 120,000g for 1 h. The sample was mixed with 1 ml of Ni-NTA Superflow resin (Qiagen) per 1 mg of GFP-His 8 and incubated for 2 h at 4 uC. Slurry was loaded onto a glass Econo-Column (Bio-Rad) and washed in 31 PBS buffer containing 0.1% DDM, 150 mM NaCl and 20 mM imidazole for 20 column volumes. Bound material was washed for a further 20 column volumes in the same buffer containing 50 mM imidazole. The ASBT NM -GFP-His 8 fusion was eluted in two column volumes of the same buffer containing 250 mM imidazole. The eluted protein was dialysed overnight in the presence of stoichiometric amounts of His 6 -tagged tobacco etch virus protease in 3 l of buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.03% DDM. Dialysed sample was passed through a 5-ml Ni-NTA His-Trap column (GE Healthcare), and the flow-through containing ASBT NM was collected. Protein was concentrated to 10 mg ml 21 using concentrators with a relative molecular mass cut-off of 100K, and was loaded onto a Superdex 200 10/300 gel filtration column (GE Healthcare) equilibrated in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.06% LDAO. The choice of the detergent LDAO was considered suitable for crystallization by comparing FSEC 33 and stability data 35 for ASBT NM with membrane proteins known to crystallize in this detergent 11 . The protein peak was collected and concentrated to 20 mg ml 21 for crystallization. Transport time course. E. coli cells harbouring wild-type ASBT NM -GFP-His 8 were collected and resuspended in uptake buffer consisting of 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM Tris-HCl, pH 7.5, and either 137 mM NaCl (Na 1 -containing buffer) or 137 mM choline chloride (Na 1 -low buffer). Cells were incubated at 37 uC with uptake buffer containing 4 mM taurocholate supplemented with 0.16 mM [2,4-3 H]-taurocholate (30 Ci mmol 21 ; American Radiolabelled Chemicals) for the indicated time intervals. Transport was terminated by the addition of ice-cold buffer containing 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM Tris-HCl, pH 7.5, 137 mM NaCl or 137 mM ChCl, and 1 mM taurocholate, and was followed immediately by centrifugation at 20,500g for 60 s. Cell pellets were washed several times in an equal volume of termination buffer and resuspended in 200 ml of the same buffer. The radioactivity corresponding to the internalized substrate was measured by scintillation counting. Each experiment was performed in triplicate. Nonspecific uptake was assessed by repeating the time course in triplicate for cells transformed with the same vector but expressing the sodium/ proton antiporter fusion NhaA-GFP-His 8 . In all experiments, ASBT NM expression was calculated on the basis of GFP fluorescence measured at 510 nm (excitation wavelength, 488 nm) using a 96-well spectrofluorometer 31 . In-gel fluorescence and FSEC data of DDM-solubilized whole cells of wild-type ASBT NM and mutants were carried out essentially as described previously 10, 33 . Transport kinetics. The accumulation of taurocholate was linear within the first 120 s. For kinetic characterization, the initial velocity of taurocholate uptake at 37 uC was measured after 120 s at the indicated increasing substrate concentrations. The radioactivity corresponding to the internalized substrate was measured by scintillation counting. Nonspecific uptake was measured by repeating the transport kinetics for cells transformed with the same vector, but expressing the sodium/proton antiporter fusion NhaA-GFP-His 8 . Specific ASBT NM uptake was calculated by the subtraction of nonspecific uptake from total uptake. Each experiment was performed in triplicate. The data were fitted to the Michaelis-Menten equation by nonlinear regression using the GRAPHPAD PRISM software. Activity of ASBT NM mutants. E. coli cells harbouring ASBT NM -GFP-His 8 mutants were resuspended in uptake buffer containing 4 mM taurocholate supplemented with 0.16 mM [2,4-3 H]-taurocholate (30 Ci mmol 21 ; American Radiolabelled Chemicals) for 5 min at 37 uC. The radioactivity corresponding to the internalized substrate was measured by scintillation counting. For each mutant, the uptake values were corrected for background by subtracting values from parallel assays carried out in the absence of sodium. Activities were plotted as percentages of the wild-type transport activity calculated in the same way. Each experiment was performed in triplicate. Substrate specificity. The whole-cell [ 3 H]-taurocholate uptake assay was carried out similarly to that described for ASBT NM mutants, except that 150 mM of either taurocholate (Sigma), cyclosporin A (Sigma), bromosulfophthalein (Sigma) or fluvastatin (Cayman Europe) was added to the uptake buffer. Crystallization and preliminary screening. Crystals were grown at 20 uC using the vapour diffusion method. Taurocholic acid (Sigma) was added to the protein solution to a final concentration of 10 mM. The protein was then mixed 1:1 with reservoir solution containing 50 mM sodium citrate, pH 4.5, 70 mM NaCl and 22-24% PEG 400. Crystals appeared overnight and reached a maximum size after 3-4 days. The crystals were frozen in liquid nitrogen and screened using synchrotron radiation at the European Synchrotron Radiation Facility and Diamond Light Source. Crystals are tetragonal with cell dimensions of approximately 75 Å 3 75 Å 3 180 Å . The best of these crystals diffract to around 2.8-3.5 Å ; however, with dehydration the diffraction increases to ,2 Å . Structure determination of a cysteine mutant of ASBT NM . As initial attempts at making heavy-atom derivatives with mercury compounds failed, Leu 87 was modified to cysteine (construct ASBT NM_1 ). The ASBT NM_1 protein crystallized similarly to the wild-type protein. Mercury-derivatized crystals were obtained from this mutant by incubating for 1 h with 1 mM mercury acetate before crystallization. A single mercury-derivatized crystal of ASBT NM_1 was used to solve the structure by single-wavelength anomalous dispersion. The crystal was frozen in liquid nitrogen and then re-annealed before data collection by leaving it in air for approximately 3 min. The re-annealing resulted in shrinkage of the unit cell and an increase in the resolution to 2.2 Å . Data were collected at the mercury edge (1.0060 Å ) on beamline I03 at the Diamond Light Source.
Data were initially processed to 2.5 Å by the XIA2 36 pipeline to XDS 37 set up on the beamline, with further processing using the CCP4 suite of programs 38 . The space group was determined to be P4 1 22, with one molecule in the asymmetric unit. An anomalous difference Patterson map showed clear peaks associated with one bound heavy atom. The heavy-atom coordinates were determined using RSPS 39 . Its position was refined and phases were calculated using SHARP 40 with solvent flattening in SOLOMON 41 . The resulting phases were input to the automatic structure building implemented in PHENIX 42 . This resulted in a model that was reasonably complete. Modification and further building of the structure was carried out in O 43 and COOT 44 . At this point, the data were reprocessed using MOSFLM 45 , extending the resolution to 2.2 Å as judged from the scaling statistics ( Supplementary Table 1 ) and the features in the resulting maps.
Structural refinement was performed in BUSTER 46 using individual isotropic B-factor refinement and TLS 47 . The complete protein was chosen as a single TLS group because no significant drop in the R free value was observed when splitting the protein into multiple groups.
Two ions were identified in the core of the protein. The residues coordinating these ions and the associated distances are consistent with their being sodium ions 48 . As an additional verification, the putative sodium ions were changed to water molecules and run through the program WASP 49 , which uses valence calculations to identify possible metal ions. After replacing all solvent and ions by water molecules as required by the program, only the two solvent molecules originally assigned as sodium ions were flagged as likely sodium ions. After all residues had been modelled, clear electron density remained in the cavity of the protein. This density was enhanced in a simulated-annealing omit map calculated in PHENIX 42 . The taurocholate structure, downloaded from the Cambridge Structural Database (accession code, KORZUM), clearly fitted the density with the cholate head group positioned at the bottom of the cavity ( Supplementary  Fig. 9b ). A further taurocholate was observed in the crystal interface. The final model has an R-factor of 19.7% and a corresponding R free value of 22.9%, and contains all protein residues from 2 to 309, two sodium ions, one mercury atom, RESEARCH LETTER two taurocholate molecules, 37 water molecules, five LDAO molecules and two truncated phospholipids (phosphatidylethanolamine). The final refinement statistics of this model, which was used to solve the wild-type protein, are summarized in Supplementary Table 2 . Structure determination and refinement of ASBT NM . Because the re-annealing of the ASBT NM_1 construct in air was not reproducible, dehydration was attempted using the humidity controller HC1 device 50 mounted on beamline I02 at the Diamond Light Source. By placing the crystal into an air stream at 45% relative humidity for 5 min before freezing it, crystals were found to reproducibly diffract to ,2.0 Å . Data were collected from a single crystal of ASBT NM on beamline I02 at the Diamond Light Source. The data were processed in XDS 37 using the XIA2 pipeline 36 and scaled at a resolution of 2.2 Å (Supplementary Table 1 ). The structure was refined, as above, starting from the final model of the ASBT NM_1 construct, minus all non-protein residues. No appreciable differences were observed in the wild-type and mercury-derivatized structures. Taurocholate and detergent molecules were modelled in the same positions as for ASBT NM_1 . The final model has an R-factor of 21.2% and an R free value of 24.4% (Supplementary Table 2 ). Structural analysis. Superpositions were carried out in LSQMAN 51 . The superpositions were performed so that only Ca pairs that were less than 3.8 Å apart were included in the calculation. The numbers quoted in the text regarding the topology-inverted repeats of ASBT NM were calculated between pairs of Ca atoms that were less than 10 Å apart. This was considered necessary to include atoms from both the V-motif and the core motif. In comparing ASBT NM with NhaA (Protein Data Bank ID, 1ZCD), only pairs of atoms less than 5 Å apart after superposition were chosen, giving an r.m.s.d. of 2.9 Å for 202 out of a possible 308 pairs of Ca atoms. The volume of the cavity was calculated in VOIDOO 52 using a probe radius of 1.4 Å . Figures showing the structure were drawn using PYMOL 53 except those showing electron density, which were made using CCP4MG 54 . Outward-facing model. As in LeuT 55 , in ASBT NM the protein is made up of two five-transmembrane-helix repeats that when superimposed show a small rotation of two transmembrane helices with respect to the other three ( Supplementary  Fig. 4 ). For LeuT, it was shown that by swapping the conformations of the N-and C-terminal topology-inverted repeats the structure can be changed from an outward-facing state to an inward-facing state 28 . In ASBT NM , the lengths of the two topology-inverted repeats are very similar. To create an outward-facing backbone model of ASBT NM , in an analogous manner to that carried out for LeuT, TM1 to TM5 were superposed on TM6 to TM10, and vice versa.
